LYC Healthcare Berhad (KLSE:LYC)
Malaysia
· Delayed Price · Currency is MYR 0.0400
0.00 (0.00%)
At close: Jun 13, 2025
LYC Healthcare Berhad Income Statement
Financials in millions MYR. Fiscal year is April - March.
Millions MYR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Revenue | 153.53 | 130.19 | 92.28 | 64.6 | 26.41 | Upgrade
|
| Revenue Growth (YoY) | 17.93% | 41.08% | 42.86% | 144.56% | 112.43% | Upgrade
|
| Cost of Revenue | 70.66 | 61.52 | 50.7 | 32.41 | 14.79 | Upgrade
|
| Gross Profit | 82.88 | 68.67 | 41.58 | 32.19 | 11.62 | Upgrade
|
| Selling, General & Admin | 81.23 | 75.37 | 39.94 | 32.15 | 18.8 | Upgrade
|
| Other Operating Expenses | -4.63 | -6.77 | -0.15 | -7.63 | -1.79 | Upgrade
|
| Operating Expenses | 76.6 | 68.6 | 40.01 | 24.55 | 17.01 | Upgrade
|
| Operating Income | 6.28 | 0.08 | 1.57 | 7.64 | -5.39 | Upgrade
|
| Interest Expense | -13.14 | -9.2 | -11.22 | -8.76 | -3.96 | Upgrade
|
| Interest & Investment Income | 0.23 | 0.39 | 0.26 | 0.11 | 0.09 | Upgrade
|
| Earnings From Equity Investments | -0.19 | -1.4 | -2.23 | -0.51 | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | -0.07 | -0.05 | -0.05 | -0.03 | Upgrade
|
| EBT Excluding Unusual Items | -6.82 | -10.2 | -11.67 | -1.58 | -9.29 | Upgrade
|
| Merger & Restructuring Charges | - | -0.07 | -0.19 | -0.29 | -0.21 | Upgrade
|
| Asset Writedown | - | -0.55 | - | - | -2.18 | Upgrade
|
| Other Unusual Items | - | - | - | 0.64 | 0.5 | Upgrade
|
| Pretax Income | -6.82 | -10.83 | -11.86 | -1.22 | -11.18 | Upgrade
|
| Income Tax Expense | 4.5 | 4.08 | 2.93 | 3.03 | 0.28 | Upgrade
|
| Earnings From Continuing Operations | -11.31 | -14.9 | -14.8 | -4.25 | -11.46 | Upgrade
|
| Net Income to Company | -11.31 | -14.9 | -14.8 | -4.25 | -11.46 | Upgrade
|
| Minority Interest in Earnings | -6.08 | -4.26 | -4.39 | -4.97 | -0.4 | Upgrade
|
| Net Income | -17.39 | -19.16 | -19.19 | -9.23 | -11.87 | Upgrade
|
| Net Income to Common | -17.39 | -19.16 | -19.19 | -9.23 | -11.87 | Upgrade
|
| Shares Outstanding (Basic) | 659 | 659 | 550 | 436 | 362 | Upgrade
|
| Shares Outstanding (Diluted) | 659 | 659 | 550 | 436 | 362 | Upgrade
|
| Shares Change (YoY) | - | 19.68% | 26.33% | 20.38% | 9.20% | Upgrade
|
| EPS (Basic) | -0.03 | -0.03 | -0.03 | -0.02 | -0.03 | Upgrade
|
| EPS (Diluted) | -0.03 | -0.03 | -0.03 | -0.02 | -0.03 | Upgrade
|
| Free Cash Flow | 15.36 | 3.45 | 2.46 | -2.54 | -5.58 | Upgrade
|
| Free Cash Flow Per Share | 0.02 | 0.01 | 0.00 | -0.01 | -0.01 | Upgrade
|
| Gross Margin | 53.98% | 52.75% | 45.06% | 49.83% | 44.00% | Upgrade
|
| Operating Margin | 4.09% | 0.06% | 1.70% | 11.83% | -20.39% | Upgrade
|
| Profit Margin | -11.33% | -14.72% | -20.79% | -14.28% | -44.92% | Upgrade
|
| Free Cash Flow Margin | 10.00% | 2.65% | 2.67% | -3.93% | -21.14% | Upgrade
|
| EBITDA | 23.6 | 6.99 | 4.84 | 10.4 | -3.24 | Upgrade
|
| EBITDA Margin | 15.37% | 5.37% | 5.24% | 16.10% | -12.28% | Upgrade
|
| D&A For EBITDA | 17.32 | 6.91 | 3.27 | 2.76 | 2.14 | Upgrade
|
| EBIT | 6.28 | 0.08 | 1.57 | 7.64 | -5.39 | Upgrade
|
| EBIT Margin | 4.09% | 0.06% | 1.70% | 11.83% | -20.39% | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.